USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) Director Gilbert A. Fuller sold 490 shares of USANA Health Sciences stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $44.59, for a total transaction of $21,849.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
USANA Health Sciences Trading Up 2.9 %
Shares of USANA Health Sciences stock opened at $46.32 on Friday. The company has a fifty day moving average price of $46.38 and a 200 day moving average price of $48.04. USANA Health Sciences, Inc. has a twelve month low of $41.45 and a twelve month high of $69.60. The stock has a market cap of $889.34 million, a price-to-earnings ratio of 14.43, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94.
USANA Health Sciences (NYSE:USNA – Get Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.35. The company had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. Analysts forecast that USANA Health Sciences, Inc. will post 2.75 earnings per share for the current year.
Hedge Funds Weigh In On USANA Health Sciences
Wall Street Analyst Weigh In
USNA has been the topic of a number of analyst reports. DA Davidson lowered their price objective on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating on the stock in a report on Tuesday. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Friday, January 12th.
Read Our Latest Stock Report on USANA Health Sciences
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories
- Five stocks we like better than USANA Health Sciences
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Will the Biotech Sector Shift From Lagger to Leader?
- The Most Important Warren Buffett Stock for Investors: His Own
- Robinhood Soars: Dissecting a Record-Breaking Q1 2024
- The How and Why of Investing in Gold Stocks
- Plug Power is Building the Future of Hydrogen Despite Headwinds
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.